MENU

• New Products

• Projects Under development

• Seeking  Products and capabilities

• Offering Products and capabilities

• Sourcing finished dosages for comparative clinical trials

• Toll production (GMP) of R&D and clinical trial lots

• Our Values

    NEWS

    MAX Pharma Canada Inc. starts using the Dun & Bradstreet's D-U-N-S® Number (Data Universal Numbering System)

    MAX Pharma Canada Inc. receives US FDA labeler code

    MAX Pharma Canada Inc. acquires four product registrations for Canada. DIN transfer process is under way with Health Canada

NEW PRODUCTS

-     Onguent Noir/ Black Ointment

-     Phenylbutazone Injection (200mg/ml of Phenylbutazone USP injectable)

-     Dipyrone 50 (500mg/ml of dipyrone monohydrate injectable)

-     VIT-E-AD (injection of Vitamin A propionate 100.000 unit/ml, Vitamin D3 (Cholecalciferol) 10.000 unit/ml and Vitamin E (D-Alpha tocopherol) 300 unit/ml)

* We are currently processing the DIN transfers with Health Canada.